From PRISMAP to PRISMAP+, we strive to support medical research by providing innovative medical radionuclides for free and supporting your research. We achieve this by combining complementary production facilities with biomedical research facilities that are licenced to receive the radionuclides from our portfolio.
We offer access to the following goods, facilities and services: